Health Catalyst Inc
For the period ended Jun 30, 2024. Filed Aug 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 8, 2024
HCAT$1.44-4.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations for theand unaudited
Condensed Consolidated Statements of Operations
(in thousands, except per share data)
| Three Months EndedJune 30, | Six Months EndedJune 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Revenue(1): | ||||
| Technology | $47,635 | $47,324 | $94,601 | $94,510 |
| Professional services | 28,267 | 25,889 | 56,024 | 52,571 |
| Total revenue | 75,902 | 73,213 | 150,625 | 147,081 |
| Cost of revenue, excluding depreciation and amortization: | ||||
| Technology | 16,067 | 15,859 | 31,382 | 30,586 |
| Professional services | 23,993 | 23,579 | 47,195 | 47,156 |
| Total cost of revenue, excluding depreciation and amortization | 40,060 | 39,438 | 78,577 | 77,742 |
| Operating expenses: | ||||
| Sales and marketing | 12,745 | 16,397 | 31,803 | 34,966 |
| Research and development | 13,884 | 17,590 | 28,755 | 34,672 |
| General and administrative | 14,363 | 23,671 | 28,927 | 47,504 |
| Depreciation and amortization | 10,657 | 10,735 | 21,182 | 21,729 |
| Total operating expenses | 51,649 | 68,393 | 110,667 | 138,871 |
| Loss from operations | (15,807) | (34,618) | (38,619) | (69,532) |
| Interest and other income, net | 2,361 | 2,090 | 4,699 | 3,883 |
| Loss before income taxes | (13,446) | (32,528) | (33,920) | (65,649) |
| Income tax provision | 70 | 85 | 183 | 154 |
| Net loss | $(13,516) | $(32,613) | $(34,103) | $(65,803) |
| Net loss per share, basic and diluted | $(0.23) | $(0.58) | $(0.58) | $(1.18) |
| Weighted-average shares outstanding used in calculating net loss per share, basic and diluted | 59,304 | 55,977 | 58,948 | 55,732 |
(1)Includes amounts attributable to related party transactions. See Note 17 for further details.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.